The Latest Breaking News from Disease

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today the signing of an exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corporation, a subsidiary of Novartis AG (NYSE:NVS), for its

Prince William said Kevin Sinfield's charity run is a "very fitting tribute" to the late Rob Burrow.

Six-year-old spanador called Ivor taught to identify tree fungal-like organism killing trees and shrubs around UK

Experts trained Ivor, a six-year-old cocker spaniel Labrador cross, to identify the highly destructive pathogen phytophthora ramorum.

With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market is thriving. Hence, fundamentally solid genomic research stocks Agilent Technologies (A), Illumina (ILMN), and 10x Genomics (TXG) could be ideal buys. Read more.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

Growing rates of infectious disease in state’s most populous region could indicate increased ‘vaccine hesitancy’

Could hitting specific numerical targets help supercharge weight loss and protect you from chronic disease? Nutritionist Louise Pyne investigates…